Oxford Biodynamics Plc - Medical Equipment - Deals and Alliances Profile.
DESCRIPTION
TABLE OF CONTENTS
RELATED REPORTS
SAMPLE REQUEST
REVIEWS
DESCRIPTION
Summary
Oxford Biodynamics Plc (Oxford Biodynamics) is a biotechnology company that discovers and develops biomarker discovery platform. The company concentrates on research in detection, monitoring and prognosis of major diseases associated with aberrant gene expression such as oncology, metabolic, inflammatory, cardiovascular and neurodegenerative conditions. Its biomarker discovery platform is used for the detection of aberrant gene expression. The companys products are used in the areas of breast cancer diagnostics, hepatocellular carcinoma diagnostics, nasopharyngeal carcinoma diagnostics, prostate cancer progression, melanoma diagnostics, and age related disease diagnostics. Oxford Bio is headquartered in Oxford, the UK.
Oxford Biodynamics Plc - Medical Equipment - Deals and Alliances Profile. provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.
Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.
Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.
Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Oxford Biodynamics Plc (Oxford Biodynamics) is a biotechnology company that discovers and develops biomarker discovery platform. The company concentrates on research in detection, monitoring and prognosis of major diseases associated with aberrant gene expression such as oncology, metabolic, inflammatory, cardiovascular and neurodegenerative conditions. Its biomarker discovery platform is used for the detection of aberrant gene expression. The companys products are used in the areas of breast cancer diagnostics, hepatocellular carcinoma diagnostics, nasopharyngeal carcinoma diagnostics, prostate cancer progression, melanoma diagnostics, and age related disease diagnostics. Oxford Bio is headquartered in Oxford, the UK.
Oxford Biodynamics Plc - Medical Equipment - Deals and Alliances Profile. provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.
Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.
Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.
Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
TABLE OF CONTENTS
2
List of Tables 3
List of Figures 4
Oxford Biodynamics Plc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Oxford Biodynamics Plc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Oxford Biodynamics Plc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Oxford Biodynamics Plc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Oxford Biodynamics Plc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Oxford Biodynamics Plc, Medical Equipment, Deal Details 10
Venture Financing 10
Oxford Biodynamics Raises US$3.2 Million In Financing 10
Partnerships 10
Nova Satra Enters into Licensing Agreement with Oxford BioDynamics 10
Oxford Biodynamics Enters Into Agreement With University of Glasgow For Epigenetic Biomarkers 11
Equity Offering 12
Oxford BioDynamics Raises USD24.9 Million in Issue of New Ordinary Shares 12
Oxford Biodynamics Plc - Key Competitors 14
Key Employees 15
Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 17
Financial Announcements 17
Jun 13, 2017: Oxford Biodynamics Interim Results For The Six-Month Period Ended 31 March 2017 17
Jan 31, 2017: Oxford BioDynamics Announces Final Results for the Year Ended 30 September 2016 24
Corporate Communications 26
Jun 30, 2017: Oxford BioDynamics: Appointment of Paul Stockdale as Chief Financial Officer 26
Mar 09, 2017: Oxford BioDynamics announces appointment of Martin Reeves as Senior Vice President of Commercial Development 27
Feb 13, 2017: Oxford BioDynamics appoints Dr Claudio Carini as an Advisor 28
Product News 29
May 31, 2017: Nature (Scientific Reports) publication highlights advantages of EpiSwitch technology platform 29
Dec 12, 2016: Oxford BioDynamics presents applications of its epigenetic biomarker technology EpiSwitch at the annual meeting of the American Society of Hematology in San Diego 30
Nov 02, 2016: Oxford BioDynamics presents applications of its epigenetic biomarkers technology at the 2nd International Annual Companion Diagnostic Summit in Berlin 31
Oct 25, 2016: Oxford BioDynamics presents results of study into epigenetic biomarkers for ALS at The Lancet Neurology Conference 32
Jan 12, 2016: Biotechnology firm Oxford BioDynamics expands its biomarker discovery programme for ALS diagnosis 33
Other Significant Developments 34
May 23, 2017: Oxford BioDynamics enters into development agreement with two top 10 global pharmaceutical companies 34
Jan 23, 2017: Oxford BioDynamics enters into pilot project with EpiFit to analyse the effect of fitness regimes using EpiSwitch 35
Appendix 37
Methodology 37
About GlobalData 37
Contact Us 37
Disclaimer 37
List Of Tables
Oxford Biodynamics Plc, Medical Equipment, Key Facts 1
Oxford Biodynamics Plc, Medical Equipment, Deals Summary, 2011 to YTD 2017 1
Oxford Biodynamics Plc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Oxford Biodynamics Plc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Oxford Biodynamics Plc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Oxford Biodynamics Plc, Deals By Market, 2011 to YTD 2017 8
Oxford Biodynamics Plc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Oxford Biodynamics Raises US$3.2 Million In Financing 10
Nova Satra Enters into Licensing Agreement with Oxford BioDynamics 10
Oxford Biodynamics Enters Into Agreement With University of Glasgow For Epigenetic Biomarkers 11
Oxford BioDynamics Raises USD24.9 Million in Issue of New Ordinary Shares 12
Oxford Biodynamics Plc, Key Competitors 14
Oxford Biodynamics Plc, Key Employees 15
Oxford Biodynamics Plc, Other Locations 16
List Of Figures
Oxford Biodynamics Plc, Medical Equipment, Deals by Type, 2011 to YTD 2017 1
Oxford Biodynamics Plc, Medical Equipment, Deals By Year, 2011 to YTD 2017 1
Oxford Biodynamics Plc, Medical Equipment, Deals By Region, 2011 to YTD 2017 1
Oxford Biodynamics Plc, Medical Equipment, Deals By Market, 2011 to YTD 2017 1
Oxford Biodynamics Plc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Oxford Biodynamics Plc, Medical Equipment, Deals by Type, 2011 to YTD 2017 6
Oxford Biodynamics Plc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Oxford Biodynamics Plc, Medical Equipment, Deals by Market, 2011 to YTD 2017 8
RELATED REPORTS
Oxford Immunotec Ltd - Product Pipeline Analysis, 2020 Update
Oxford Immunotec Ltd (Oxford Immunotec) a subsidiary of Oxford Immunotec Global Plc is a medical device company that offers proprietary tests for immune-regulated conditions. The company offers in vitro diagnostic,
View ReportOxford Immunotec Ltd - Product Pipeline Analysis, 2019 Update
Oxford Immunotec Ltd (Oxford Immunotec) a subsidiary of Oxford Immunotec Global Plc is a medical device company that offers proprietary tests for immune-regulated conditions. The company offers in vitro diagnostic,
View ReportSAMPLE REQUEST
Fill The Form For Sample Request
REVIEWS
